Author

F. Potus

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. Bourgeois· 2 shared C. Romanet· 2 shared C. Theberge· 2 shared M. Sauvaget· 2 shared O. Boucherat· 2 shared S. Bonnet· 2 shared S. Breuils-Bonnet· 2 shared S. Martineau· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

A. Bourgeois

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical Studies

S.-E. Lemay, M. S. Montesinos, Y. Grobs, T. Yokokawa, T. Shimauchi, C. Romanet, M. Sauvaget, S. Breuils-Bonnet, A. Bourgeois, C. Theberge, A. Pelletier, R. El Kabbout, S. Martineau, K. Yamamoto, A. S. Ray, , S. Bonnet

The study identifies integrin α5β1 as a key driver of pulmonary vascular remodeling in PAH and shows its inhibition improves hemodynamics and RV function in preclinical models.

bioRxiv · May 27, 2024Pathology

ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic Reprograming.

Y. Grobs, C. Romanet, S.-E. Lemay, A. Bourgeois, P. Voisine, C. Theberge, M. Sauvaget, S. Breuils-Bonnet, S. Martineau, R. El-kabbout, M. Mougin, E. Dumais, J. Perron, N. Flamand, F. Potus, , s. Bonnet

This study identifies ATP-citrate lyase as a driver of vascular remodeling in pulmonary hypertension and coronary artery disease, showing its inhibition can reverse pathological changes.

bioRxiv · Feb 2, 2024 · PreprintPhysiology